International S.c.a. Artal, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 2,426,070 shares at $2.50 ($6.1M) on 2022-08-05, disclosed to the SEC on 2022-08-09.
Open-market purchase of $6.1M LXRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| WTW | SELL | 2018-08-16 | $456.0M | — | Filing → |
| WTW | BUY | 2014-08-19 | $1.2M | — | Filing → |